INTERFERON ALFA-2B: 2,075 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,075
Total FAERS Reports
145 (7.0%)
Deaths Reported
389
Hospitalizations
2,075
As Primary/Secondary Suspect
70
Life-Threatening
41
Disabilities
Prescription
Status
FDA Application: 103132 ·
First Report: 1991 · Latest Report: 20240828
What Are the Most Common INTERFERON ALFA-2B Side Effects?
#1 Most Reported
Product use in unapproved indication
224 reports (10.8%)
#2 Most Reported
Off label use
207 reports (10.0%)
#3 Most Reported
Fatigue
206 reports (9.9%)
All INTERFERON ALFA-2B Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Product use in unapproved indication | 224 | 10.8% | 20 | 18 |
| Off label use | 207 | 10.0% | 8 | 27 |
| Fatigue | 206 | 9.9% | 5 | 26 |
| Nausea | 120 | 5.8% | 4 | 20 |
| Influenza like illness | 105 | 5.1% | 0 | 8 |
| Drug ineffective | 94 | 4.5% | 7 | 10 |
| Product use issue | 86 | 4.1% | 10 | 5 |
| Headache | 80 | 3.9% | 0 | 13 |
| Pyrexia | 80 | 3.9% | 6 | 33 |
| No adverse event | 76 | 3.7% | 0 | 0 |
| Adverse event | 65 | 3.1% | 2 | 24 |
| Malaise | 62 | 3.0% | 2 | 23 |
| Death | 60 | 2.9% | 59 | 13 |
| Diarrhoea | 57 | 2.8% | 3 | 11 |
| Decreased appetite | 55 | 2.7% | 3 | 17 |
| Neutropenia | 50 | 2.4% | 10 | 15 |
| Pain | 49 | 2.4% | 2 | 12 |
| Anaemia | 46 | 2.2% | 4 | 27 |
| Chills | 46 | 2.2% | 1 | 10 |
| Depression | 44 | 2.1% | 1 | 8 |
Who Reports INTERFERON ALFA-2B Side Effects? Age & Gender Data
Gender: 48.6% female, 51.4% male. Average age: 53.2 years. Most reports from: US. View detailed demographics →
Is INTERFERON ALFA-2B Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 2 | 0 | 0 |
| 2001 | 5 | 0 | 3 |
| 2002 | 9 | 0 | 7 |
| 2003 | 4 | 0 | 1 |
| 2004 | 8 | 0 | 3 |
| 2005 | 7 | 0 | 2 |
| 2006 | 6 | 1 | 1 |
| 2007 | 11 | 0 | 0 |
| 2008 | 8 | 0 | 2 |
| 2009 | 6 | 0 | 1 |
| 2010 | 6 | 1 | 1 |
| 2011 | 15 | 1 | 3 |
| 2012 | 73 | 3 | 36 |
| 2013 | 99 | 5 | 36 |
| 2014 | 211 | 24 | 86 |
| 2015 | 112 | 20 | 35 |
| 2016 | 123 | 11 | 26 |
| 2017 | 143 | 11 | 20 |
| 2018 | 115 | 7 | 15 |
| 2019 | 105 | 8 | 10 |
| 2020 | 68 | 3 | 6 |
| 2021 | 20 | 2 | 3 |
| 2022 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
What Is INTERFERON ALFA-2B Used For?
| Indication | Reports |
|---|---|
| Malignant melanoma | 190 |
| Hepatitis c | 137 |
| Cutaneous t-cell lymphoma | 83 |
| Mycosis fungoides | 81 |
| Product used for unknown indication | 79 |
| Chronic hepatitis c | 77 |
| Bladder cancer | 65 |
| Covid-19 | 43 |
| Adult t-cell lymphoma/leukaemia | 29 |
| Chronic myeloid leukaemia | 29 |
INTERFERON ALFA-2B vs Alternatives: Which Is Safer?
INTERFERON ALFA-2B vs INTERFERON BETA
INTERFERON ALFA-2B vs INTERFERON BETA-1A
INTERFERON ALFA-2B vs INTERFERON BETA-1B
INTERFERON ALFA-2B vs INTERFERON GAMMA
INTERFERON ALFA-2B vs INTERFERON GAMMA-1B
INTERFERON ALFA-2B vs INVEGA
INTERFERON ALFA-2B vs INVEGA SUSTENNA
INTERFERON ALFA-2B vs INVESTIGATIONAL BIOSIMILARS
INTERFERON ALFA-2B vs INVESTIGATIONAL PRODUCT
INTERFERON ALFA-2B vs INVOKANA
Official FDA Label for INTERFERON ALFA-2B
Official prescribing information from the FDA-approved drug label.